Labcorp to pay $2.1M in third party overbilling case
By 
Adrianne Appel2023-03-28T18:43:00
Laboratory Corporation of America (Labcorp) agreed to pay $2.1 million to settle allegations the company overbilled the Department of Defense (DoD) for genetic tests performed by a third party.
The Department of Justice (DOJ) announced the settlement Monday for violations of the False Claims Act (FCA). The complaint against Labcorp was originally filed by a former employee, Donna Hecker-Gross, under the qui tam provisions of the FCA. Hecker-Gross will receive $357,000 from the settlement amount.
The details: Labcorp entered into a contract with the DoD in 2012 to provide testing services for U.S. military worldwide. The company then subcontracted with GeneDx to conduct specialty genetic tests. GeneDx billed LabCorp for the tests, and Labcorp would then bill the DoD.
THIS IS MEMBERS-ONLY CONTENT
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
Related articles
-
PremiumThree TPRM myths worth busting
There are stories we tell ourselves in third-party risk management (TPRM) to make ourselves feel better about the corners we cut.
-
News Brief
DOJ: Former Magellan quality control director, execs misled public over lead tests
The former director of quality assurance at Magellan Diagnostics allegedly conspired with executives to conceal a critical flaw in lead tests they knew would result in tens of thousands of false negative tests among lead-exposed children.
-
News BriefGenotox Laboratories to pay $5.9M in DOJ kickback settlement
Genotox Laboratories agreed to pay at least $5.9 million to settle charges it violated the False Claims Act by paying volume-based commissions to third-party marketers and submitting claims to federal healthcare programs for unnecessary drug tests.
More from Regulatory Enforcement
-
ArticleCMA holds companies responsible for false claims, fake reviews ‘throughout supply chain’
Companies face large fines if they spread false marketing claims or fake reviews about their products and services—as well as those by suppliers—under a toughened competition regime in the U.K. aimed at enhancing consumer protection.
-
ArticleFTC warns VISA and other processors that company policies may lead to debanking
Visa, Mastercard, PayPal, and Stripe have received letters from the Federal Trade Commission, warning the companies to end any policies or terms of service that may result in the “debanking” of customers.
-
ArticleDOJ makes good on corporate-friendly enforcement policy with Balt resolution
The ink was barely dry on the U.S. Department of Justice’s new corporate enforcement policy (CEP) when the agency announced it would not prosecute Balt SAS for alleged bribery violations.